Mount Sinai’s Alison Snow, PhD, MSW, Named 2026 Oncology Social Worker of the Year
Alison Snow, PhD, MSW, OSW-C, Senior Director of Oncology Social Work and Cancer Supportive Services at the Mount Sinai Health System, has been named the 2026 Oncology Social Worker of the Year by the Board of Oncology Social Work Certification (BOSWC). The honor recognizes certified oncology social workers who demonstrate exceptional leadership, professional service, and dedication to advancing cancer care through psychosocial support.
“I am deeply honored to receive this recognition and I’m incredibly grateful to represent the oncology social work community,” said Dr. Snow, who is also co-director of Mount Sinai’s Center of Excellence for Cancer Support Services. “Oncology social workers play a critical role in helping patients and families navigate the emotional, practical, and financial challenges that come with a cancer diagnosis. This award reflects the dedication of the incredible teams across our Health System I’ve had the privilege to work with, and I hope it continues to shine a light on the importance of psychosocial support as an essential part of comprehensive cancer care.”
Dr. Snow was selected as the inaugural recipient of the award through a national nomination and review process conducted by the BOSWC Board of Directors. The award highlights her sustained contributions to oncology social work and her commitment to supporting patients and families navigating the challenges of cancer.
“At Mount Sinai, our oncology social workers play a vital role in supporting patients and their families throughout every stage of cancer care,” said Jane Wallace, MS, Vice President, Mount Sinai Health System, Oncology and Therapeutic Infusion Services. “Alison has been instrumental in advancing compassionate, patient-centered support programs across our cancer centers. Her leadership and dedication to the field make her deeply deserving of this national recognition.”
Through the Center of Excellence for Cancer Support Services at Mount Sinai, oncology social workers provide counseling, care coordination, and resources that help patients cope with the psychological and social effects of cancer diagnosis and treatment. Under Dr. Snow’s leadership, Mount Sinai has continued to expand services that address the emotional well-being of patients while helping them navigate complex medical and financial systems.
“Social workers are essential members of the cancer care team, helping patients and families manage the profound life changes that come with a cancer diagnosis,” said Carol DeJesus, LCSW, CCM, Vice President for Care Transitions and Population Health, Mount Sinai Morningside. “Alison exemplifies the highest standards of our profession. Her work strengthens the support systems patients rely on and advances the role of oncology social work within our entire Health System.”
The Oncology Social Worker of the Year Award recognizes individuals who have made meaningful contributions to the oncology social work profession while promoting the value of certification. The award will be presented annually during Social Work Month in March.
About the Icahn School of Medicine at Mount Sinai
The Icahn School of Medicine at Mount Sinai is internationally renowned for its outstanding research, educational, and clinical care programs. It is the sole academic partner for the seven member hospitals* of the Mount Sinai Health System, one of the largest academic health systems in the United States, providing care to New York City’s large and diverse patient population.
The Icahn School of Medicine at Mount Sinai offers highly competitive MD, PhD, MD-PhD, and master’s degree programs, with enrollment of more than 1,200 students. It has the largest graduate medical education program in the country, with more than 2,600 clinical residents and fellows training throughout the Health System. Its Graduate School of Biomedical Sciences offers 13 degree-granting programs, conducts innovative basic and translational research, and trains more than 560 postdoctoral research fellows.
Ranked 11th nationwide in National Institutes of Health (NIH) funding, the Icahn School of Medicine at Mount Sinai is among the 99th percentile in research dollars per investigator according to the Association of American Medical Colleges. More than 4,500 scientists, educators, and clinicians work within and across dozens of academic departments and multidisciplinary institutes with an emphasis on translational research and therapeutics. Through Mount Sinai Innovation Partners (MSIP), the Health System facilitates the real-world application and commercialization of medical breakthroughs made at Mount Sinai.
-------------------------------------------------------
* Mount Sinai Health System member hospitals: The Mount Sinai Hospital; Mount Sinai Brooklyn; Mount Sinai Morningside; Mount Sinai Queens; Mount Sinai South Nassau; Mount Sinai West; and New York Eye and Ear Infirmary of Mount Sinai.
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. The Health System includes approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses across seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, a school of nursing, and schools of medicine and graduate school of biomedical sciences.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York and recognized as one of the world’s top Smart Hospital by Newsweek. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools for National Institutes of Health (NIH) funding and No. 1 among freestanding medical schools, reflecting the strength of its scientific enterprise and leadership in biomedical research.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Instagram, LinkedIn, X, and YouTube. To listen to news and stories from Mount Sinai, visit the Mount Sinai Podcast Network.